Pentagon Eyes Search for Virus-Fighting Protein ‘Cocktails’

None

Diane Barnes
See more stories about...
Diane Barnes
Oct. 4, 2013, 10:02 a.m.

WASH­ING­TON — The U.S. De­fense De­part­ment is weigh­ing a new search for im­mune-pro­tein “cock­tails” it hopes will pro­tect hu­mans against Ebola and oth­er deadly, weapon-us­able vir­uses.

The Pentagon two weeks ago in­vited sci­ent­ists to sub­mit re­search pro­pos­als for design­ing “mono­clonal an­ti­bod­ies” that could pro­tect against Ebola and Mar­burg, as well as “al­phavir­uses” such as Venezuelan equine en­ceph­al­it­is.

Pentagon plan­ners have been turn­ing to an­ti­bod­ies as a pos­sible tool be­cause “no easy and quick fix” for such agents has emerged from ef­forts to de­vel­op vac­cines or tra­di­tion­al an­ti­vir­al treat­ments, said Gigi Gron­vall, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter.

The early-stage re­search now un­der con­sid­er­a­tion ideally would lead to single-shot treat­ments cap­able of guard­ing troops for months from mul­tiple vir­us types, the De­fense Threat Re­duc­tion Agency said in a Sept. 18 so­li­cit­a­tion. DTRA of­fi­cials wel­comed re­search­ers to pro­pose “‘cock­tails’ that may en­able cross-pro­tec­tion against mul­tiple spe­cies of vir­us.”

The em­phas­is on “cock­tails” makes the latest DTRA pro­pos­al par­tic­u­larly not­able, be­cause sev­er­al stud­ies sug­gest that mixes of sev­er­al an­ti­bod­ies can be par­tic­u­larly ef­fect­ive in fight­ing patho­gens, Gron­vall told Glob­al Se­cur­ity News­wire in a tele­phone in­ter­view. An­ti­bod­ies hit their tar­gets with such spe­cificity that a treat­ment with mul­tiple im­mune pro­teins can help ac­count for slight vari­ations between in­vad­ing mi­crobes.

Mono­clonal an­ti­bod­ies have been in use since the 1980s to treat can­cer and im­mune-linked ail­ments such as rheum­at­oid arth­rit­is, but their use against in­fec­tious patho­gens has lagged, ac­cord­ing to a DTRA-sponsored re­port co-au­thored by Gron­vall on the tech­no­logy’s biode­fense po­ten­tial.

The United States last year li­censed the first in­hal­a­tion an­thrax treat­ment to use the tech­no­logy, which in­volves cre­at­ing massive quant­it­ies of a single im­mune “an­ti­body.” The hu­man body nat­ur­ally gen­er­ates such pro­teins, each of which is de­signed to mark a spe­cif­ic patho­gen or tox­in for elim­in­a­tion by oth­er im­mune-sys­tem com­pon­ents.

One an­ti­body cock­tail grown in mod­i­fied to­bacco plants showed prom­ising po­tency against Ebola in­fec­tions spe­cific­ally, ac­cord­ing to a study pub­lished in Au­gust.

“There have been a lot of changes in the way that mono­clonal an­ti­body tech­no­lo­gies have evolved over the last sev­er­al years, and it makes mono­clonal an­ti­bod­ies a very nice piece of their ap­proach to med­ic­al coun­ter­meas­ures,”  Gron­vall said.

The latest DTRA Broad Agency An­nounce­ment seeks pro­pos­als for stud­ies no longer than one year, with a cost no great­er than $500 mil­lion. The fil­ing dead­line is Oct. 16.

What We're Following See More »
‘PULLING A TRUMP’
GOP Budget Chiefs Won’t Invite Administration to Testify
1 days ago
THE DETAILS

The administration will release its 2017 budget blueprint tomorrow, but the House and Senate budget committees won’t be inviting anyone from the White House to come talk about it. “The chairmen of the House and Senate Budget committees released a joint statement saying it simply wasn’t worth their time” to hear from OMB Director Shaun Donovan. Accusing the members of pulling a “Donald Trump,” White House spokesman Josh Earnest said the move “raises some questions about how confident they are about the kinds of arguments that they could make.”

Source:
A DARK CLOUD OVER TRUMP?
Snowstorm Could Impact Primary Turnout
1 days ago
THE LATEST

A snowstorm is supposed to hit New Hampshire today and “linger into Primary Tuesday.” GOP consultant Ron Kaufman said lower turnout should help candidates who have spent a lot of time in the state tending to retail politicking. Donald Trump “has acknowledged that he needs to step up his ground-game, and a heavy snowfall could depress his figures relative to more organized candidates.”

Source:
IN CASE OF EMERGENCY
A Shake-Up in the Offing in the Clinton Camp?
1 days ago
THE DETAILS

Anticipating a primary loss in New Hampshire on Tuesday, Hillary and Bill Clinton “are considering staffing and strategy changes” to their campaign. Sources tell Politico that the Clintons are likely to layer over top officials with experienced talent, rather than fire their staff en masse.

Source:
THE LAST ROUND OF NEW HAMPSHIRE POLLS
Trump Is Still Ahead, but Who’s in Second?
22 hours ago
THE LATEST

We may not be talking about New Hampshire primary polls for another three-and-a-half years, so here goes:

  • American Research Group’s tracking poll has Donald Trump in the lead with 30% support, followed by Marco Rubio and John Kasich tying for second place at 16%. On the Democratic side, Bernie Sanders leads Hillary Clinton 53%-41%.
  • The 7 News/UMass Lowell tracking poll has Trump way out front with 34%, followed by Rubio and Ted Cruz with 13% apiece. Among the Democrats, Sanders is in front 56%-40%.
  • A Gravis poll puts Trump ahead with 28%, followed by Kasich with 17% and Rubio with 15%.
IT’S ALL ABOUT SECOND PLACE
CNN Calls the Primary for Sanders and Trump
9 hours ago
THE LATEST

Well that didn’t take long. CNN has already declared Bernie Sanders and Donald Trump the winners of the New Hampshire primary, leaving the rest of the candidates to fight for the scraps. Five minutes later, the Associated Press echoed CNN’s call.

Source:
×